Filing status
- Accounts due
- 27 December 2026
- Last accounts
- 27 March 2025
- Conf. stmt due
- 14 September 2027
- Last conf. stmt
- 31 August 2026
Respiratory Clinical Trials Limited
- Incorporated
- 31 August 2000 (26 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Owned by
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- 1 Tower HouseTower CentreHoddesdonEN11 8UR
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 9 May 2002
British
Born September 1954 (72)
Secretary · Appointed 9 May 2002
British
Officer history (6 former)
19 November 2021
9 May 2002
9 May 2002
9 May 2002
9 May 2002
Resigned Hansel, Trevor Thomas, Dr as Director
9 May 2002
1 March 2001
31 August 2000
31 August 2000
31 August 2000
31 August 2000
31 August 2000
31 August 2000
Appointed Hansel, Trevor Thomas, Dr as Director
31 August 2000
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 27 November 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited
Reg. no. 11044713
Former controllers (1)
27 November 2017
Group structure 7 companies
Ownership group derived from the Companies House PSC register
Nephro-Urology Clinical Trials Ltd. Owns 75–100% of shares
Queen Anne Street Medical Centre Limited Owns 75–100% of shares
Essex Health Care Alliance Limited Owns 75–100% of shares
Queen Anne Street Essex Medical Limited Owns 50–75% of shares
Respiratory Clinical Trials Limited This company Owns 75–100% of shares
The Heart Lung Centre Limited Owns 50–75% of shares
Financials
Balance sheet as at 27 March 2025 · total exemption full accounts
- Net Assets
- (£860,044)
- Cash
- (£200)
- Debt Ratio
- 885%
- Current Ratio
- 0.1x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £63 | £63 | £63 | £63 | £63 | £63 |
| Current Assets | £109,525 | £109,525 | £113,187 | £113,547 | £121,668 | £705,458 |
| Debtors | £109,725 | £109,725 | £113,259 | £113,259 | £118,189 | £703,170 |
| Cash | (£200) | (£200) | (£72) | £288 | £3,479 | £2,128 |
| Creditors (< 1 year) | £899,333 | £899,333 | £901,811 | £901,811 | £906,741 | £1,500,216 |
| Creditors (> 1 year) | £70,299 | £70,299 | £70,299 | £70,299 | £70,299 | £70,299 |
| Net Current Assets | (£789,808) | (£789,808) | (£788,624) | (£788,264) | (£785,073) | (£794,758) |
| Net Assets | (£860,044) | (£860,044) | (£858,860) | (£858,500) | (£855,309) | (£864,994) |
| Shareholder Funds | (£860,044) | (£860,044) | (£858,860) | (£858,500) | (£855,309) | (£864,994) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 3 September 2026 | Confirmation statement with updates | 31 August 2026 | ||
| 23 March 2026 | Total exemption full accounts | 27 March 2025 | ||
| 23 December 2025 | Previous accounting period shortened | |||
| 4 September 2025 | Notification of a person with significant control | |||
| 4 September 2025 | Cessation of a person with significant control |
Some other companies at this address
Other companies in this industry
Manchester
Hartley Wintney
Pampisford
Cambridge
Chalgrove
Runcorn
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →